Oxford Biomedica Share News (OXB)

Flat speaker technology developer NXT says revenues have been below expectations since the beginning of 2010. New product delays have not helped and those products that were launched had disappointing sales. Royalty revenues from portable speakers were lower than expected. NXT needs to sign additional licences in order to achieve 2010 expectations. The £1m raised in February means that NXT has enough cash for its immediate needs. NXT acquired the intellectual property of Audium in April. Audium has audio power amplifier technology that enables batteries to last longer. Shares in Oxford Biomedica moved ahead after the board withdrew an AGM resolution that would have allowed it to issue new shares equivalent to up to 10% of the share capital without offering them to existing shareholders. The proxy votes cast ahead of the meeting suggested to the gene therapy company that it would not get the requisite number of votes to succeed in getting rid of pre-emption rights to existing shareholders. FTSE TechMARK - RisersSkyepharma (SKP) 50.00p +4.17%Puricore (PURI) 12.75p +4.08%Antisoma (ASM) 7.49p +3.60%E2V Technologies (E2V) 57.50p +2.22%KCOM Group (KCOM) 46.00p +2.22%Trafficmaster (TFC) 38.25p +2.00%Axis-Shield (ASD) 438.00p +1.62%Phoenix IT Group (PNX) 257.00p +1.58%BATM Advanced (BVC) 43.25p +0.58%Oxford Biomedica (OXB) 9.80p +0.51%FTSE TechMARK - FallersNXT (NTX) 13.25p -5.36%Alterian (ALN) 168.00p -3.45%Intec Telecom Systems (ITL) 63.25p -2.32%Sepura (SEPU) 46.50p -2.11%Dialight (DIA) 247.50p -1.98%Vectura Group (VEC) 38.00p -1.94%Renovo Group (RNVO) 25.50p -1.92%Innovation Group (TIG) 13.00p -1.89%Alphameric (ALM) 27.50p -1.79%RM Group (RM.) 180.00p -1.77%